These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 13921051)

  • 1. Modification of metabolism and distribution of lipids by ethyl chlorophenoxyisobutyrate.
    THORP JM; WARING WS
    Nature; 1962 Jun; 194():948-9. PubMed ID: 13921051
    [No Abstract]   [Full Text] [Related]  

  • 2. THE EFFECT OF SF 20-10-5 CONCENTRATION CHANGES INDUCED BY ETHYL CHLOROPHENOXYISOBUTYRATE ON HIGH-DENSITY LIPOPROTEIN LIPID COMPOSITION.
    STRISOWER EH; NICHOLS AV; LINDGREN FT; SMITH L
    J Lab Clin Med; 1965 May; 65():748-55. PubMed ID: 14281371
    [No Abstract]   [Full Text] [Related]  

  • 3. STUDIES WITH ETHYL CHLOROPHENOXYISOBUTYRATE (CLOFIBRATE).
    AZARNOFF DL; TUCKER DR; BARR GA
    Metabolism; 1965 Sep; 14():959-65. PubMed ID: 14327272
    [No Abstract]   [Full Text] [Related]  

  • 4. A COMPARISON OF THE EFFECTS OF ETHYL CHLOROPHENOXYISOBUTYRATE AND NICOTINIC ACID ON PLASMA FREE FATTY ACIDS.
    DUNCAN CH; BEST MM; ROBERTSON GL
    Lancet; 1965 Jan; 1(7378):191-3. PubMed ID: 14238047
    [No Abstract]   [Full Text] [Related]  

  • 5. HYPOLIPEMIA AND HEPATOMEGALY FROM ETHYL CHLOROPHENOXYISOBUTYRATE (CPIB) IN THE RAT.
    BEST MM; DUNCAN CH
    J Lab Clin Med; 1964 Oct; 64():634-42. PubMed ID: 14233152
    [No Abstract]   [Full Text] [Related]  

  • 6. THE SEPARATE HYPOLIPOPROTEINEMIC EFFECTS OF DEXTROTHYROXINE AND ETHYL CHLOROPHENOXYISOBUTYRATE.
    STRISOWER EH; STRISOWER B
    J Clin Endocrinol Metab; 1964 Feb; 24():139-44. PubMed ID: 14123837
    [No Abstract]   [Full Text] [Related]  

  • 7. [CHOLESTEROL AND BLOOD LIPID BEHAVIOR IN ARTERIOSCLEROSIS UNDER THE EFFECTS OF PROTECTED ANDROSTERONE (ATROMID)].
    MARIN R; GARCIAFERNANDEZ JL; GARCIAOTERO V; RODRIGUEZPUCHOL J; PESCADOR L
    Rev Esp Cardiol; 1964 Jul; 17():563-73. PubMed ID: 14232044
    [No Abstract]   [Full Text] [Related]  

  • 8. REDUCTION OF SERUM CHOLESTEROL AND LIPIDS BY ETHYL CHLOROPHENOXYISOBUTYRATE.
    HELLMAN L; ZUMOFF B; KESSLER G; KARA E; RUBIN IL; ROSENFELD RS
    J Atheroscler Res; 1963; 3():454-66. PubMed ID: 14100886
    [No Abstract]   [Full Text] [Related]  

  • 9. EFFECTS OF ETHYL CHLOROPHENOXYISOBUTYRATE, ALONE OR WITH ANDROSTERONE (ATROMID) ON SERUM LIPIDS, LIPOPROTEINS AND RELATED METABOLIC PARAMETERS IN NORMAL AND HYPERLIPIDEMIC SUBJECTS.
    HOWARD RP; ALAUPOVIC P; BRUSCO OJ; FURMAN RH
    J Atheroscler Res; 1963; 3():482-99. PubMed ID: 14100889
    [No Abstract]   [Full Text] [Related]  

  • 10. EFFECT OF ETHYL CHLOROPHENOXYISOBUTYRATE WITH OR WITHOUT ANDROSTERONE ON PLATELET STICKINESS.
    SYMONS C; DETOSZEGHI A; COOK IJ
    Lancet; 1964 Aug; 2(7353):233-4. PubMed ID: 14163151
    [No Abstract]   [Full Text] [Related]  

  • 11. FURTHER OBSERVATIONS ON THE EFFECTS OF ATROMID AND OF ETHYL CHLOROPHENOXYISOBUTYRATE ON SERUM LIPID LEVELS.
    OLIVER MF
    J Atheroscler Res; 1963; 3():427-44. PubMed ID: 14100884
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of ethyl alpha-p-chlorophenoxyisobutyrate (Clofibrate) on lipids, cholesterol and uric acid in diabetes mellitus].
    Orsetti A; Mirouze J
    Therapie; 1966; 21(3):685-91. PubMed ID: 5942133
    [No Abstract]   [Full Text] [Related]  

  • 13. THE RESPONSE OF HYPERLIPOPROTEINEMIAS TO ATROMID AND ETHYL CHLOROPHENOXYISOBUTYRATE.
    STRISOWER EH
    J Atheroscler Res; 1963; 3():445-53. PubMed ID: 14100885
    [No Abstract]   [Full Text] [Related]  

  • 14. THE EFFECT OF ETHYL CHLOROPHENOXYISOBUTYRATE ON THE BINDING BETWEEN TRIIODOTHYRONINE AND PROTEIN.
    MOGENSEN EF
    J Atheroscler Res; 1963; 3():415-7. PubMed ID: 14100882
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of ethyl chlorophenoxyisobutyrate on postprandial lipemia].
    Beaumont JL; Menard J; Beaumont V
    Rev Atheroscler (Paris); 1966; 8(1):21-6. PubMed ID: 5960551
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of ethyl-p-chlorophenoxyisobutyrate, clofibrate, on the plasma and red blood cell free fatty acids of the rat.
    Cenedella RJ; Jarrell JJ; Saxe LH
    J Atheroscler Res; 1968; 8(6):903-11. PubMed ID: 5707796
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of atromid and ethyl chlorophenoxyisobutyrate on anticoagulant requirements.
    OLIVER MF; ROBERTS SD; HAYES D; PANTRIDGE JF; SUZMAN MM; BERSOHN I
    Lancet; 1963 Jan; 1(7273):143-4. PubMed ID: 13940003
    [No Abstract]   [Full Text] [Related]  

  • 18. ETHYL CHLOROPHENOXYISOBUTYRATE COMBINED WITH CORTICOSTEROIDS IN BRONCHIAL ASTHMA.
    KENNEDY MC
    J Atheroscler Res; 1963; 3():418-24. PubMed ID: 14100883
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hypolipemic agents].
    Paoletti R; Fumagalli R; Sirtori R
    Minerva Med; 1973 Apr; 64(24):1267-75. PubMed ID: 4707410
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of ethofibrate [2-(nicotinoyloxy)ethyl-p-chlorophenoxyisobutyrate] on lipid metabolism. I. Effect on blood lipids in normal and hyperlipemic rats].
    Maroto ML; Priego JG; Piña M; Catalán RE
    Arch Farmacol Toxicol; 1978 Apr; 4(1):25-7. PubMed ID: 697396
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.